Chinese Traditional and Herbal Drugs
|
2025, 56(8): 2735-2747
Pharmacodynamic material basis of Danggui Liuhuang Decoction for intervening hyperthyroidism based on chinmedomics
Full
GUAN Yu1, ZHANG Yongyan1, SHEN Kunshuang1, MENG Guangjie1, GAO Huiru1, CHE Yanning2, WANG Xijun1
Affiliations
1 State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Chinmedomics Research Center, Heilongjiang University of Chinese Medicine, Harbin 150040, China;
2 Harbin No. 4 Chinese Medicine Factory Co., Ltd., Harbin 150500, China
doi: 10.7501/j.issn.0253-2670.2025.08.010
Outline
Objective To systematically evaluate the interventional effect of Danggui Liuhuang Decoction (当归六黄汤, DGLHD) on hyperthyroidism, discover the relevant pharmacodynamic material basis, and elucidate its mechanism of action, thereby providing scientific evidence for the subsequent development of DGLHD. Methods A hyperthyroidism rat model was prepared by using levothyroxine sodium, and the metabolic profile and biomarkers of the hyperthyroidism model were characterized by chinmedomics; the interventional effect of DGLHD on hyperthyroidism was evaluated by using the classical pharmacological parameters of the model as the indexes, and the blood migratory constituents of DGLHD were analyzed under the effective state, and the correlation between the blood migratory constituents of DGLHD and the biomarkers of the model was explored by Pearson Correlation between Marker Metabolites and Serum Constituents (PCMS) method to reveal the pharmacodynamic material basis of DGLHD intervention in hyperthyroidism. Results DGLHD had a modulating effect on the abnormalities of body weight, heart rate, anal temperature, food intake and respiratory quotient of hyperthyroidism model rats; it significantly regulated the biochemical indexes of triiodothyronine, thyroxine, free triiodothyronine, free thyroxine and thyroid-stimulating hormone; it altered the metabolic trajectory of the blood in the hyperthyroidism model rats, and regulated the disturbed expression of 18 markers such as 1H-indole-3-carboxaldehyde. It inhibited the expression of inflammatory factors and played the role of immunomodulation by regulating the metabolic pathways such as glycerophospholipid metabolism, primary bile acid biosynthesis and steroid hormone biosynthesis. In the serum of rats treated with DGLHD, a total of 46 blood components were characterized, of which 38 were correlated with the blood metabolic biomarkers of hyperthyroidism, with 13 components, including senkyunolide I, identified as critical pharmacodynamic substances demonstrating high relevance to the therapeutic intervention. Conclusion It is found that components such as senkyunolide I in DGLHD could inhibit inflammatory factors, improve metabolism, and regulate immune function by regulating metabolic network disorders such as glycerophospholipid metabolism. This study provides a scientific basis for the establishment of the quality standard of DGLHD and the creation of new drugs based on thepharmacodynamic material basis.
Danggui Liuhuang Decoction
/
hyperthyroidism
/
chinmedomics
/
pharmacodynamic material basis
/
metabolomics
/
senkyunolide I
/
baicalin
关瑜, 张咏妍, 沈昆双, 孟广杰, 高慧如, 车延柠, 王喜军.
基于方证代谢组学的当归六黄汤干预甲状腺功能亢进症的药效物质基础研究.
中草药,
2025
, 56
(8)
: 2735
-2747
.
DOI: 10.7501/j.issn.0253-2670.2025.08.010
GUAN Yu, ZHANG Yongyan, SHEN Kunshuang, MENG Guangjie, GAO Huiru, CHE Yanning, WANG Xijun.
Pharmacodynamic material basis of Danggui Liuhuang Decoction for intervening hyperthyroidism based on chinmedomics[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(8)
: 2735
-2747
.
DOI: 10.7501/j.issn.0253-2670.2025.08.010
Year 2025 volume 56 Issue 8
47
9
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.08.010
- Receive Date:2024-12-30
- Online Date:2026-11-13